Cymbalta
Stevens-Johnson Syndrome Cymbalta Risk
Cymbalta Can Cause Serious Skin Disease. Cymbalta, the antidepressant and anti-anxiety medication manufactured by Eli Lilly, can cause a serious and sometimes fatal skin condition called Stevens-Johnson Syndrome (SJS). Some medications cause SJS, causing the skin to burn from the inside out and leading to blisters, severe rashes and … [Read more...] about Stevens-Johnson Syndrome Cymbalta Risk
Cymbalta Antidepressant Drug (generic: duloxetine) Side Effects May Lead To Suicide, Birth Defect or Withdrawal Symptoms Lawsuits
Cymbalta Side Effects Include: Suicidal Thoughts, Liver Disease, Birth Defects, Cleft Palate, Heart Valve Damage, SSRI - Personal Injury Lawyers On December 13, 2006, the FDA announced antidepressants prescribed to young adults are risky. The agency proposed expanding the labels of all antidepressants to include an … [Read more...] about Cymbalta Antidepressant Drug (generic: duloxetine) Side Effects May Lead To Suicide, Birth Defect or Withdrawal Symptoms Lawsuits
Cymbalta Suicide Data
Cymbalta Suicide Data. Cymbalta, an antidepressant made by Eli Lilly, has been linked to suicides. Although suicide is sometimes the tragic outcome of depression, some of those who have committed suicide while taking Cymbalta were not being treated for depression - or for any other mental illness. Unfortunately, despite reports of … [Read more...] about Cymbalta Suicide Data
Cymbalta Diabetic Nerve Pain Claims Deceptive
Cymbalta Diabetic Nerve Pain. A new Cymbalta marketing campaign makes deceptive claims about the anti-depressant’s benefits and downplays its dangers. Now, the Food & Drug Administration (FDA) is telling Cymbalta’s maker, Eli Lilly, to end the promotion. Cymbalta is used to treat depression, anxiety and diabetic nerve … [Read more...] about Cymbalta Diabetic Nerve Pain Claims Deceptive
FDA Criticizes Cymbalta’s Medical Journal Ads
Cymbalta Medical Journal Ads Has Been Scrutinized. Eli Lilly & Co. failed to make the risks of its Cymbalta medicine clear enough in medical journal advertisements that promoted the drug to treat nerve pain caused by diabetes, U.S. regulators said. In a letter to Lilly posted Wednesday on the U.S. Food and Drug … [Read more...] about FDA Criticizes Cymbalta’s Medical Journal Ads
Cymbalta to Carry Expanded Warning
Cymbalta May Cause Serious Liver-Related Problems. The Food and Drug Administration (FDA) and Eli Lilly have notified healthcare professionals of a significant revision to the PRECAUTIONS/Hepatotoxicity section of the prescribing information for ‘Cymbalta’ (duloxetine hydrochloride); Lilly’s antidepressant indicated for treatment of … [Read more...] about Cymbalta to Carry Expanded Warning
